Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein¶
Why this mattered¶
In the Cell paper, Walls and colleagues helped turn SARS-CoV-2 from a newly sequenced threat into a structurally tractable target. The study showed that the spike glycoprotein uses ACE2 for entry, that its receptor-binding domain binds human ACE2 with affinity comparable to SARS-CoV, that the spike contains a processed furin-cleavage site absent from SARS-CoV, and that the trimer samples receptor-accessible conformations. This mattered because it made the central problem concrete: infection, neutralization, vaccine design, and viral evolution could all be studied through a defined molecular machine rather than through the virus as a black box.
The immediate practical shift was from empirical vaccine and therapeutic development toward structure-guided intervention. The cryo-EM spike structures supplied a blueprint for stabilizing, presenting, and targeting the prefusion spike, while the antigenicity experiments showed that antibodies raised against SARS-CoV spike could inhibit SARS-CoV-2 spike-mediated entry, pointing to conserved vulnerable epitopes. After this paper, researchers could rationally design immunogens, screen neutralizing antibodies, build pseudovirus assays, and interpret escape mutations against a shared structural reference.
Its longer-term importance became clearer as COVID-19 countermeasures matured. The dominant vaccine, monoclonal antibody, and variant-surveillance programs all treated spike conformation, ACE2 engagement, cleavage, glycan shielding, and neutralizing epitopes as the main explanatory framework. Later breakthroughs, including rapid mRNA vaccine deployment, isolation of potent neutralizing antibodies, and structural analysis of Alpha, Beta, Delta, Omicron, and subsequent immune-escape variants, depended on the paradigm this work exemplified: pandemic response could be accelerated by solving the pathogen’s key antigen at near-atomic resolution early enough to guide the biology, not merely explain it afterward.
Abstract¶
(no abstract available)
Related¶
- cite → Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia — The SARS-CoV-2 spike study compares coronavirus spike structure and receptor entry mechanisms against the previously identified MERS-CoV.
- cite → Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China — The spike glycoprotein paper uses early Wuhan clinical reports to frame SARS-CoV-2 as the cause of severe human pneumonia.
- cite → A pneumonia outbreak associated with a new coronavirus of probable bat origin — The spike glycoprotein paper relies on the bat-origin coronavirus report for SARS-CoV-2 genome identity and zoonotic context.
- cite → Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation — Both papers determine the SARS-CoV-2 spike trimer in its prefusion conformation by cryo-electron microscopy.
- enables ← Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia — Isolation of MERS-CoV characterized a pathogenic coronavirus and its spike-mediated entry, informing comparative spike structure and antigenicity work on SARS-CoV-2.